Skip to main content

Closed

CADL: Candel Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-28.9%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-16.7×

Current ratio28.05×

Candel Therapeutics, Inc.

CADLNASDAQ Global Market·USD·Closed

Candel Therapeutics, Inc.

CADLNASDAQ·USD·Closed

$10.01

+1.42%

$10.01

+$0.14 (1.42%)

52W Range

81thpctl

Volume

0.57×avg

Mkt Cap

733.43MUSD

P/E

-9.8TTM

Div Yield

–ann

52W Range

81thpctl

Volume

0.57×avg

Market Cap

733.43MUSD

P/E Ratio

-9.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings